Primary Prevention
Conditions
Keywords
Immunization, Boot Camp Translation, Adolescent, Human Papillomavirus, Vaccine
Brief summary
The overarching goal of this project is to implement Boot Camp Translation (BCT) methodology to translate the guidelines and evidence for human papillomavirus (HPV) vaccine into a practice and provider level intervention designed to improve its acceptability and uptake.
Detailed description
As a community engagement approach, Boot Camp Translation (BCT), is a 6-9-month iterative process that brings together multiple stakeholders, including patients, parents, and community members, to translate evidence-based guidelines and recommendations into locally relevant and meaningful messages, materials, and programs. Aim 1: Implement BCT in three geographically distinct Colorado communities to translate the current evidence for HPV vaccination into locally relevant interventions designed to increase vaccine uptake. Aim 2: Evaluate the impact of the BCT- designed intervention on practice-level HPV vaccination initiation rates. The long-term goal is to develop a replicable approach and low-cost method of increasing HPV vaccine uptake that is easily adaptable to different settings and sociodemographic contexts.
Interventions
BEHAVIORALBoot Camp Translation
Practices in the intervention arm will participate in the Boot Camp Translation process, where BCT Community Advisory group members will come together to develop and implement practice relevant materials to promote adolescent vaccination.
OTHERControl
No intervention. Practices will continue to behave as usual.
Sponsors
National Institutes of Health (NIH)
National Cancer Institute (NCI)
University of Colorado, Denver
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
9 Years to 26 Years
Healthy volunteers
No
Inclusion criteria
All child patients who have received health supervision at participating practices during the 12 month prior to intervention and the 12 month following intervention implementation, who are ages 9-26 years, and whose parents have not requested removal from the Colorado Immunization Information System (CIIS) will be eligible for the assessment of practice immunization rates in the pre and post periods.
Exclusion criteria
* No subjects will be excluded because of gender, ethnicity, or insurance status. * Any child whose parents have requested removal from the immunization registry; any child with hypersensitivity to any component of one of the recommended vaccines; any child who has moved to a primary care provider other than one at the study clinics.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Initiation of HPV vaccination series, 9-17 | Up to 12 months | Percent of 9-17 year olds who have received \>=1 dose of the HPV vaccine by September 29, 2021 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Differences in initiation rates between intervention vs. control, 13-17 | 12 months | Comparison of boys vs. girls who have received \>1=dose of HPV vaccine by September 29, 2021 |
| Differences in initiation rates between intervention vs. control, 18-26 | 12 months | Percent of 18-26 year olds who have received \>=1 dose of the HPV vaccine by September 29, 2021 |
| Differences in initiation rates between intervention vs. control, 9-10 | 12 months | Comparison of boys vs. girls who have received \>1=dose of HPV vaccine by September 29, 2021 |
| Differences in initiation rates between intervention vs. control, 11-12 | 12 months | Comparison of boys vs. girls who have received \>1=dose of HPV vaccine by September 29, 2021 |
Countries
United States
Outcome results
None listed